Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep-Oct;25(9-10):550-558.
doi: 10.1111/1751-2980.13217. Epub 2023 Sep 14.

Endoscopic resection of gastrointestinal stromal tumors

Affiliations
Review

Endoscopic resection of gastrointestinal stromal tumors

Bing Qian Cheng et al. J Dig Dis. 2024 Sep-Oct.

Abstract

Surgical resection is regarded as the main modality for the treatment of gastrointestinal stromal tumors (GISTs). With the advancement of endoscopic techniques and the introduction of super minimally invasive surgery (SMIS), endoscopic resection has been an alternative option to surgery. Recently, various endoscopic resection techniques have been used for the treatment of GISTs, including endoscopic submucosal dissection (ESD), endoscopic submucosal excavation (ESE), endoscopic full-thickness resection (EFR), submucosal tunneling endoscopic resection (STER), and laparoscopic and endoscopic cooperative surgery (LECS). Studies on the safety and efficacy of the endoscopic treatment of GISTs have emerged in recent years. Endoscopic resection techniques have demonstrated to be effective and safe for the treatment of GISTs. However, there is currently no consensus on the optimal follow-up strategy and the appropriate cut-off value of tumor size for endoscopic resection. In this review we discussed the indications, preoperative preparation, procedures, efficacy, safety, postoperative evaluation, follow-up, and perspectives of endoscopic resection modalities for GISTs.

Keywords: endoscopic resection; gastrointestinal stromal tumors; therapeutic endoscopy.

PubMed Disclaimer

References

REFERENCES

    1. Amadeo B, Penel N, Coindre JM, et al. Incidence and time trends of sarcoma (2000–2013): results from the French network of cancer registries (FRANCIM). BMC Cancer. 2020;20(1):190. doi:10.1186/s12885‐020‐6683‐0
    1. Joensuu H, Hohenberger P, Corless CL. Gastrointestinal stromal tumour. Lancet. 2013;382(9896):973‐983.
    1. Corless CL, Barnett CM, Heinrich MC. Gastrointestinal stromal tumours: origin and molecular oncology. Nat Rev Cancer. 2011;11(12):865‐878.
    1. Xu L, Ma YP, Wang SF, et al. Incidence of gastrointestinal stromal tumor in Chinese urban population: a national population‐based study. Cancer Med. 2021;10(2):737‐744.
    1. Alfagih A, AlJassim A, Alshamsan B, Alqahtani N, Asmis T. Gastrointestinal stromal tumors: 10‐year experience in cancer center—the Ottawa Hospital (TOH). Curr Oncol. 2022;29(10):7148‐7157.

MeSH terms

LinkOut - more resources